Wrexham, United Kingdom

Romain Bejot

This inventor holds 1 USPTO granted patent. Top assignee: Ariceum Therapeutics Gmbh. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Romain Bejot. Retrieved from https://idiyas.com/inventor/romain-bejot-bu7zehq7

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Romain Bejot: Innovator in Radiopharmaceuticals

Introduction

Romain Bejot is a notable inventor based in Wrexham, GB. He has made significant contributions to the field of radiopharmaceuticals, particularly through his innovative work on somatostatin analogues. His expertise and dedication to advancing medical technology have positioned him as a key figure in his industry.

Latest Patents

Romain Bejot holds 1 patent for a composition containing a somatostatin analogue for radiopharmaceutical use. This invention focuses on a receptor-selective somatostatin peptide antagonist, which is designed for both diagnostic and therapeutic applications. The implications of this patent are substantial, as it enhances the potential for targeted treatments in medical practice.

Career Highlights

Throughout his career, Romain has been associated with Ariceum Therapeutics GmbH, where he has played a pivotal role in research and development. His work has contributed to the advancement of innovative solutions in the medical field, particularly in the area of cancer diagnostics and treatment.

Collaborations

Romain Bejot has collaborated with talented professionals such as Bilal Karaaoui and Didier Kubiak. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, ultimately leading to groundbreaking advancements in their field.

Conclusion

Romain Bejot's contributions to radiopharmaceuticals exemplify the impact of innovation in medicine. His work not only enhances diagnostic and therapeutic options but also reflects the importance of collaboration in scientific research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…